People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aria Diagnostics, Inc. | — | Biotechnology | Series C | $65.2M | $2.2B | 2011 |
John Steulpnagel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Steulpnagel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryan Roberts | 1 | 18 |
| Kim Kamdar | 1 | 6 |
| Bryan E. Roberts | 1 | 6 |
| John Stuelpnagel | 1 | 3 |
| Kenneth Song | 1 | 2 |
| Michael E. Mitchell | 1 | 2 |
| Michael Mitchell | 1 | 2 |
| Bill Young | 1 | 1 |
| Hallie Mitchell | 1 | 1 |
| Kim E. Kamdar | 1 | 1 |
| Bill E. Young | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.